Background: Cryptococcal meningitis continues to be one of the common causes of chronic central nervous system infection worldwide. Individuals with cryptococcal meningitis can occasionally present with small vessel vasculitis causing infarcts primarily in the basal ganglia, internal capsule, and thalamus. Literature regarding patterns of cerebrovascular injury among patients with cryptococcal meningitis is scanty, and outcome following these vascular involvements is unknown.
Introduction
Cryptococcal meningitis (CCM) is a common cause of chronic central nervous system (CNS) infection worldwide. More than 80% of the cases are seen in HIV-positive patients. It is an important opportunistic infection in patients with a compromised cellular immune response. Clinically, CCM presents as subacute to chronic meningitis and meningoencephalitis with occasional focal neurological deficits. 1 Patients with CCM can often present with small vessel vasculitis causing infarcts which can be single or multiple. These infarcts can be seen in the basal ganglia, internal capsule, and thalamus. 2 Literature regarding CNS infarcts in patients with CCM is mostly from a single study. 3 The objective of this study was to describe the demographic characteristics, risk factors, clinical profile, imaging findings, and details of vascular territory involved among patients admitted with CCM and cerebral infarct from a tertiary care center. We also aim to compare the outcomes of patients of CCM with and without CNS infarcts in terms of mortality and morbidity.
Methodology
Christian Medical College, Vellore is a tertiary care health center located in South India. This retrospective observational study was conducted among patients seen in the Department of General Medicine, Radiology, and Infectious Disease of Christian Medical College, Vellore. All patients with a microbiologically proven diagnosis of CCM between May 2004 and August 2015 (11 years) were eligible to be enrolled into the study. Patients were included if cerebrospinal fluid (CSF) fungal culture had grown Cryptococcos neofrmans and/or India ink preparation of CSF showed the presence of the organism. Patients with only positive antigen tests were not included in the study. Patients who were identified to have culture proven co-infections were excluded from the study. Among patients who had a microbiologically proven diagnosis of CCM, those with an appropriate imaging in order to detect infarcts were included into the study. Patients with suboptimal imaging were also excluded from the study. A new onset infarct in the back ground of chronic meningitis as demonstrated by imaging was defined as cerebral infarct in keeping with the definition of World Health Organization.
In patients with clinical features of subacute/chronic meningitis, non-contrast computed tomography (CT) scan of the brain was performed routinely before doing a CSF analysis. Subsequently, 30% (22) of these patients required magnetic resonance imaging (MRI) of the brain due to the presence of focal neurological deficit which could not be explained with the initial imaging, and unexplained persistence or worsening of neurological symptoms and signs. Following recruitment details of baseline demography, clinical symptoms, signs, and laboratory parameters, details of treatment, and duration of treatment and hospital stay were obtained from the hospital electronic medical record data base by two trained clinicians independently. The presence of infarct, patterns of CNS involvement, and types of vascular injury on imaging were analyzed by two independent radiologists. The presence of a contrast-enhanced CT imaging (CT Cþ) or an MRI was consented as the optimal method of diagnosing infarct in order to avoid inclusion of cryptococcomas, dilated venules, and artifacts. Clinical parameters, laboratory parameters, radiological parameters, and outcomes were recorded in a pre-specified proforma. Details of site, size, type, and number of infarcts along with other radiological finding such as the presence of hydrocephalus, meningeal enhancement, basal exudates, and cryptococcomas were obtained by the radiologist. Infarcts were divided into large vessel, lacunar type based on involvement of larger vessels, or perforating arteries. The presence of more than one infarct in imaging was defined as multiple. The primary outcome was death. Good outcome was attributed to those patients who had completed treatment and recovered from their meningitis and were discharged in stable condition. Poor outcome included (1) patients who had succumbed to their illness, (2) patients who were discharged against medical advice, (3) patients who were discharged in moribund condition at request, and (4) patients who had refused to undergo medical treatment. Data recruitment was done by trained clinicians. The senior radiologist's decision was taken as final in case of any disagreement among the radiologists and the senior clinician's decision was taken as final for clinical, treatment, and outcome-related queries. Data analysis was done with statistical package for social sciences (SPSS version 16). This study was conducted after obtaining approval from the Institutional Review Board Committee.
Results
Of the 151 patients with culture-proven CCM, only 66 fulfilled the inclusion criteria and were included into this study as shown in Figure 1 . Twenty (13%) of these patients were found to have cerebral infarcts. The mean age of patients with infarct was 41 years (20-63). Among both the groups, 75% of the patients were male ( Table 1) . As compared to 57% of patients without infarct, only 15% of patients with infarct presented within one month of onset of symptoms. However, 63% with infarct and 26% of patients without infarct presented within one to three months.
Headache was present in more than 90% of patients, fever in 80%, and vomiting was present in more than 50% of patients with or without infarct. Depressed sensorium at the time of presentation was higher (53%) among patients with infarct as compared to those without infarct (37%). Seizures and cranial nerve deficits (vision loss, hearing loss, facial asymmetry, and others) were seen in 20% of patients with and without infarct.
While 65% of patients with infarct had HIV, 96% of patients without infarct had HIV. Risk factors such as diabetes and hypertension was seen in very few patients (15%) with infarcts. History of dyslipidaemia, coronary artery disease, and previous transient ischemic attack or stroke were absent in both the groups. The mean CD4 among the patients with HIV was 89.14 (3-494) as compared to patients without HIV with 399.3 (163-690). The mean GCS was 13 for both the subgroups. A GCS score of less than 15 was present in 9 (45%) of patients with infarct as compared to 17 (37%) of patients without infarct. Neck stiffness and papilledema was present in 70% and 25% patients in both the groups simultaneously. Among all the patients with infarcts, only three had focal motor deficit. While only one patient had a left-sided hemiparesis with left-sided UMN facial palsy, the other two patients had paraparesis and lower limb monoparesis, respectively. Cranial nerve deficits were present in 16 (25%) of patients as shown in Table 1 . Among these, 11 patients had decline in vision including papilledema and 5 patients had lateral rectus palsy. In an independent review of patients with decline in vision, it was not found to be related to cerebral infarcts. Due to small number of patients with lateral rectus palsy and motor deficit, we were not able to establish any association.
Blood counts, CSF lymphocytes percentage, blood, and CSF culture results were similar in both the groups as shown in Table 1 . CSF white blood cell counts and glucose was lesser in the patients with infarct as compared to CSF protein which was higher. Most patients (85%) received Amphotericin-based combined treatment across both the groups for a mean duration of 13 days (1-42 days) and a median duration of 14 days. Mean and median duration of hospital stay was 18 days and 17 days, respectively. Patients with infarct had four extra days of hospital stay as compared to patients without infarcts. Poor outcome was 50% higher among patients with infarcts, and mortality was double as compared to patients without infarct as shown in Table 1 .
As compared to 65% of patients with infarcts, only 15% of patients without an infarct had an MRI of the brain. Meningeal enhancement, cryptococcoma, and basal exudates were higher in patients with infarct as shown in Table 2 . Almost all the infarcts were of lacunar type, and 60% of these were acute as confirmed by MRI with diffusion-weighted imaging. Seventy percent of these infarcts were unilateral, and 50% were multiple. The most common site of involvement was basal ganglia, frontal lobe, parietal lobe, and thalamus in descending order (Figures 2 and 3) . The odds of poor outcome and mortality in patients with neurovascular involvement over those without the same were 9.1 and 2.6, respectively. In a logistic regression, symptoms of more than one month (p ¼ 0.017), presence of diabetes (p ¼ 0.022) and hypertension (p ¼ 0.072), HIV negativity (p ¼ 0.002), and worse outcome (p ¼ 0.000) showed a statistically significant association with the presence of infarct (Table 3) .
Discussion
CCM can present as acute, subacute, or chronic meningitis. Neurological complications following CCM can be multiple. The presence of focal neurological deficit, vision loss, deafness, cranial nerve deficits, declining memory, and worsening sensorium are common. [4] [5] [6] Globally, CCM is an important cause of significant morbidity and mortality in both immunocompetent and immunocompromised patients. Mortality is reported to be lesser in developed countries (10-12%) as compared to developing countries (27-35%). 1, 5 The predictors of poor outcome that have been identified are severe immunosuppression, comatose state at presentation, high cryptococcal antigen titre, increase intracranial pressure, and low CSF glucose and inflammatory cells. 4 In our study, features of severe cryptococcal infection such as depressed sensorium, low CSF glucose, and low CSF pleocytosis was higher among patients with CCM and infarct. However, these parameters were not statistically significant.
In recent years, there has been a significant rise in literature on vascular involvement following various International Journal of Stroke, 13(1) International Journal of Stroke, 13 (1) infections resulting in cerebral infarcts. 7 The understanding of association of CVA with CCM has evolved over the last 10 years. There have been multiple published case reports and a single case series of 11 patients with CCM presenting as cerebral infarcts. 2, 3, 8, 9 The patterns of vascular involvement, risk factors, and outcomes following cerebral infarcts among CCM patients remain unclear. This study consists of the largest number of patients with CCM presenting with infarcts. A comparison of risk factors and outcome of patients with CCM with and without CVA has been done. In our study, the incidence of infarcts was 13%. This could be because we included both HIV-positive and HIV-negative patients with CCM. The incidence of CCM with infarct in a non-HIV population has been reported as 4%. Among our study patients, the incidence of infarcts was higher in the non-HIV population (78%) as compared to HIV population (22%). 10 Patients with HIV and AIDS are known to have higher risk of cerebral infarcts as compared to International Journal of Stroke, 13(1) general population and patients without AIDS. 11, 12 Similarly, patients with CNS infections secondary to Cytomegalovirus (CMV), Herpes Zoster virus (HZV), Tuberculosis (TB), Syphillis, Toxoplasmosis are known to have vascular involvement. 8, 13 In view of the above, we excluded six patients who had culture-proven co-infections (2: TB, 1 each of HZV, CMV, Toxoplasma, and Syphilis). CNS imaging findings in International Journal of Stroke, 13 (1) CCM is contributory but non-pathognomonic. Dilated virchow robin spaces with fungus and mucoid material can resemble infarct, and pseudocysts can also have diffusion restriction in MRI. 9, 14 This led to the exclusion of patients with a substandard plain CT and need of assessment of the imaging findings by two independent radiologist.
Various mechanisms that has been attributed in development of these infarctions are as follows:
1. Inflammation and strangulation of vessels leading to spasm, constriction, and thrombosis while passing through the basal exudates. 3 In our study, basal exudates were present in 15% of the patients with infarct, being characteristically absent in the control group. 2. Progressive spread of meningeal inflammation ultimately affecting entire vessel wall and causing thrombosis. 3 Meningeal enhancement was higher in patients with infarcts in our study. 3. Stretching of inflamed vessels due to dilated ventricles. 15 In our study, hydrocephalus was seen equally in both the arms.
The presence of the above imaging features in less than 50% of patients, which points towards multifaceted etiology or the presence of alternate mechanisms such as genetic predisposition and immune-mediated mechanisms, acquired prothrombotic states which require further investigation.
Elevated ESR and HSCRP have been shown to be associated with infarcts suggesting an elevated inflammatory response in tubercular meningitis (TBM). Similarly, the presence of anti-phospholipid antibody, anti-cardiolipin antibody, elevated factor VIII level, and protein S deficiency has been identified in patients with TBM suggesting a procoagulant status. 7, 8, 11 In view of retrospective nature of the study, the above laboratory parameters were not available. Infections can also precipitate the vulnerability of atherosclerotic plaque and hence lead to infarction. In our study, 77% of patients with HIV did not have infarct as compared to 22% of patients without HIV. There was a statistically significant difference in the presence of infarcts between HIV and non-HIV patients (p ¼ 0.002). A recent study showed that dexamethasone used as an adjunctive therapy to reduce inflammation and intracranial pressure, resulted in harm in CCM. 16 Based on the results of our study and the above study, we can draw a conclusion that inflammation causing endothelial injury may not be the only mechanism for infarcts in CCM.
Infarcts secondary to CCM are mostly of the lacunar type suggesting small vessel disease. These tend to be acute, unilateral, and multiple. These infarcts are predominantly located in basal ganglia, internal capsule, and thalamus similar to other chronic meningitis. 3, 17 This pattern of involvement has been attributed to the involvement of circle of Willis by basal exudates of chronic meningitis. 3 Involvement of large intracranial vessel has been reported in few case reports. However, the reported patients were older than 55 years and had been reported to have various comorbidities like hypertension, dyslipidaemia, diabetes, obesity, cirrhosis, and granulomatosis with polyangitis. 2, 14 Other uncommon neurovascular manifestations that has been reported are bilateral cerebellar involvement, recurrent infarctions, and progressive vascular dementia. 9, 18, 19 Patients with CCM and infarcts are known to have high mortality and significant neurological deficit. 3 In our subgroup of patients, poor outcome was 50% higher among patients with infarcts and mortality was twice as compared to patients without infarct which is significantly higher than reported previously. 12 In this study, all investigations including the neuroimaging were self-financed; hence, all the patients did not have an MRI brain, and the possibility of bias due to lower detection rates of small acute infarcts in those who only had a CT brain is evident. Given the resource-limited nature of the clinical setting where the study was done, angiography, cardiac investigations such as holter, echocardiography, vasculitis work up was not feasible in most of the patients. We did not have validated details of functional independence in all the patients at the time of discharge as well. In view of retrospective nature of the study and small sample size, we were not able to draw any conclusion. Details of initiation and optimization of antiretroviral therapy was not available. It is possible that their impact on the outcome studied might have been underestimated.
In summary, neurovascular involvement in CCM is a rare entity. These tend to present as multiple lacunar infarcts. Patients with neurovascular involvement can have higher mortality and morbidity. These results suggest that vascular injury plays a crucial role in predicting outcome of patients with CCM. Symptoms of more than one month, HIV negativity, and poor outcome are significantly associated with the presence of infarct. Further studies are needed to understand the mechanism by which vascular events (infarcts) occur and result in poor outcome.
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